請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52518
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林頌然(Sung-Jan Lin) | |
dc.contributor.author | Ting-Han Chien | en |
dc.contributor.author | 簡廷翰 | zh_TW |
dc.date.accessioned | 2021-06-15T16:17:13Z | - |
dc.date.available | 2019-09-17 | |
dc.date.copyright | 2015-09-17 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-17 | |
dc.identifier.citation | [1] W. A. Pusey, 'Roentgen-rays in the treatment of skin diseases and for the removal of hair,' Journal of Cutaneous and Genitourinary Diseases, vol. 18, pp. 302-318, 1900.
[2] S. Tousey, Medical Electricity Röntgen Rays and Radium: With a Practical Chapter on Phototherapy: Saunders, 1915. [3] 'Radiation Therapy and You: Support for People With Cancer,' N. C. Institute, Ed., ed. U.S.A., 2012, pp. 21-50. [4] N. Carelle, E. Piotto, A. Bellanger, J. Germanaud, A. Thuillier, and D. Khayat, 'Changing patient perceptions of the side effects of cancer chemotherapy,' Cancer, vol. 95, pp. 155-63, Jul 1 2002. [5] M. R. Schneider, R. Schmidt-Ullrich, and R. Paus, 'The hair follicle as a dynamic miniorgan,' Curr Biol, vol. 19, pp. R132-42, Feb 10 2009. [6] K. M. Osorio, S. E. Lee, D. J. McDermitt, S. K. Waghmare, Y. V. Zhang, H. N. Woo, et al., 'Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation,' Development, vol. 135, pp. 1059-68, Mar 2008. [7] C. A. Jahoda, K. A. Horne, and R. F. Oliver, 'Induction of hair growth by implantation of cultured dermal papilla cells,' Nature, vol. 311, pp. 560-2, Oct 11-17 1984. [8] S. Muller-Rover, B. Handjiski, C. van der Veen, S. Eichmuller, K. Foitzik, I. A. McKay, et al., 'A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages,' J Invest Dermatol, vol. 117, pp. 3-15, Jul 2001. [9] L. Alonso and E. Fuchs, 'The hair cycle,' J Cell Sci, vol. 119, pp. 391-3, Feb 1 2006. [10] D. Citrin, A. P. Cotrim, F. Hyodo, B. J. Baum, M. C. Krishna, and J. B. Mitchell, 'Radioprotectors and mitigators of radiation-induced normal tissue injury,' Oncologist, vol. 15, pp. 360-71, 2010. [11] G. Sulli, R. Di Micco, and F. d'Adda di Fagagna, 'Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer,' Nat Rev Cancer, vol. 12, pp. 709-20, Oct 2012. [12] M. F. Lavin, 'Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer,' Nat Rev Mol Cell Biol, vol. 9, pp. 759-69, Oct 2008. [13] T. Helleday, E. Petermann, C. Lundin, B. Hodgson, and R. A. Sharma, 'DNA repair pathways as targets for cancer therapy,' Nat Rev Cancer, vol. 8, pp. 193-204, Mar 2008. [14] C. J. Lord and A. Ashworth, 'The DNA damage response and cancer therapy,' Nature, vol. 481, pp. 287-94, Jan 19 2012. [15] S. Postel-Vinay, E. Vanhecke, K. A. Olaussen, C. J. Lord, A. Ashworth, and J. C. Soria, 'The potential of exploiting DNA-repair defects for optimizing lung cancer treatment,' Nat Rev Clin Oncol, vol. 9, pp. 144-55, Mar 2012. [16] B. D. Price and A. D. D'Andrea, 'Chromatin remodeling at DNA double-strand breaks,' Cell, vol. 152, pp. 1344-54, Mar 14 2013. [17] R. Paus, I. S. Haslam, A. A. Sharov, and V. A. Botchkarev, 'Pathobiology of chemotherapy-induced hair loss,' Lancet Oncol, vol. 14, pp. e50-9, Feb 2013. [18] J. B. Brown and F. McDowell, 'EPITHELIAL HEALING AND THE TRANSPLANTATION OF SKIN,' Ann Surg, vol. 115, pp. 1166-81, Jun 1942. [19] M. Ito, Y. Liu, Z. Yang, J. Nguyen, F. Liang, R. J. Morris, et al., 'Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis,' Nat Med, vol. 11, pp. 1351-4, Dec 2005. [20] M. Ito and K. Kizawa, 'Expression of calcium-binding S100 proteins A4 and A6 in regions of the epithelial sac associated with the onset of hair follicle regeneration,' J Invest Dermatol, vol. 116, pp. 956-63, Jun 2001. [21] F. N. Ghadially, 'Effect of trauma on growth of hair,' Nature, vol. 181, p. 993, Apr 5 1958. [22] M. Ito, Z. Yang, T. Andl, C. Cui, N. Kim, S. E. Millar, et al., 'Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding,' Nature, vol. 447, pp. 316-20, May 17 2007. [23] S. Jiang, L. Zhao, T. Teklemariam, and B. M. Hantash, 'Small cutaneous wounds induce telogen to anagen transition of murine hair follicle stem cells,' J Dermatol Sci, vol. 60, pp. 143-50, Dec 2010. [24] D. T. Woodley, J. D. Chen, J. P. Kim, Y. Sarret, T. Iwasaki, Y. H. Kim, et al., 'Re-epithelialization. Human keratinocyte locomotion,' Dermatol Clin, vol. 11, pp. 641-6, Oct 1993. [25] M. Andjelkovic, D. R. Alessi, R. Meier, A. Fernandez, N. J. Lamb, M. Frech, et al., 'Role of translocation in the activation and function of protein kinase B,' J Biol Chem, vol. 272, pp. 31515-24, Dec 12 1997. [26] K. Murayama, T. Kimura, M. Tarutani, M. Tomooka, R. Hayashi, M. Okabe, et al., 'Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors,' Oncogene, vol. 26, pp. 4882-8, Jul 19 2007. [27] C. H. Squarize, R. M. Castilho, T. H. Bugge, and J. S. Gutkind, 'Accelerated wound healing by mTOR activation in genetically defined mouse models,' PLoS One, vol. 5, p. e10643, 2010. [28] T. Li and G. Wang, 'Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities,' Int J Mol Sci, vol. 15, pp. 18856-91, 2014. [29] R. M. Castilho, C. H. Squarize, and J. S. Gutkind, 'Exploiting PI3K/mTOR signaling to accelerate epithelial wound healing,' Oral Dis, vol. 19, pp. 551-8, Sep 2013. [30] M. B. Omary and N. O. Ku, 'Cell biology: skin care by keratins,' Nature, vol. 441, pp. 296-7, May 18 2006. [31] L. Feldmeyer, G. F. Hofbauer, T. Boni, L. E. French, and J. Hafner, 'Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing,' Br J Dermatol, vol. 166, pp. 422-4, Feb 2012. [32] L. Zhang, L. Liu, Z. He, G. Li, J. Liu, Z. Song, et al., 'Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin,' Hepatology, vol. 61, pp. 2030-41, Jun 2015. [33] A. J. Kellenberger and M. Tauchi, 'Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles,' Exp Dermatol, vol. 22, pp. 77-80, Jan 2013. [34] M. Laplante and D. M. Sabatini, 'mTOR signaling in growth control and disease,' Cell, vol. 149, pp. 274-93, Apr 13 2012. [35] D. H. Kim, D. D. Sarbassov, S. M. Ali, J. E. King, R. R. Latek, H. Erdjument-Bromage, et al., 'mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery,' Cell, vol. 110, pp. 163-75, Jul 26 2002. [36] T. R. Peterson, M. Laplante, C. C. Thoreen, Y. Sancak, S. A. Kang, W. M. Kuehl, et al., 'DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival,' Cell, vol. 137, pp. 873-86, May 29 2009. [37] Y. Sancak, C. C. Thoreen, T. R. Peterson, R. A. Lindquist, S. A. Kang, E. Spooner, et al., 'PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase,' Mol Cell, vol. 25, pp. 903-15, Mar 23 2007. [38] D. H. Kim, D. D. Sarbassov, S. M. Ali, R. R. Latek, K. V. Guntur, H. Erdjument-Bromage, et al., 'GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR,' Mol Cell, vol. 11, pp. 895-904, Apr 2003. [39] K. Inoki, T. Zhu, and K. L. Guan, 'TSC2 mediates cellular energy response to control cell growth and survival,' Cell, vol. 115, pp. 577-90, Nov 26 2003. [40] X. M. Ma and J. Blenis, 'Molecular mechanisms of mTOR-mediated translational control,' Nat Rev Mol Cell Biol, vol. 10, pp. 307-18, May 2009. [41] E. Jacinto, R. Loewith, A. Schmidt, S. Lin, M. A. Ruegg, A. Hall, et al., 'Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive,' Nat Cell Biol, vol. 6, pp. 1122-8, Nov 2004. [42] E. Jacinto, V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, et al., 'SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity,' Cell, vol. 127, pp. 125-37, Oct 6 2006. [43] L. R. Pearce, E. M. Sommer, K. Sakamoto, S. Wullschleger, and D. R. Alessi, 'Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney,' Biochem J, vol. 436, pp. 169-79, May 15 2011. [44] J. M. Garcia-Martinez and D. R. Alessi, 'mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1),' Biochem J, vol. 416, pp. 375-85, Dec 15 2008. [45] D. D. Sarbassov, S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, et al., 'Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB,' Mol Cell, vol. 22, pp. 159-68, Apr 21 2006. [46] A. Y. Choo, S. O. Yoon, S. G. Kim, P. P. Roux, and J. Blenis, 'Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation,' Proc Natl Acad Sci U S A, vol. 105, pp. 17414-9, Nov 11 2008. [47] C. C. Thoreen, S. A. Kang, J. W. Chang, Q. Liu, J. Zhang, Y. Gao, et al., 'An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1,' J Biol Chem, vol. 284, pp. 8023-32, Mar 20 2009. [48] J. Li, S. G. Kim, and J. Blenis, 'Rapamycin: one drug, many effects,' Cell Metab, vol. 19, pp. 373-9, Mar 4 2014. [49] L. Yu, Z. F. Shang, J. Wang, H. Wang, F. Huang, Z. Zhang, et al., 'PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability,' Oncotarget, May 11 2015. [50] L. Zhang, J. Wu, M. T. Ling, L. Zhao, and K. N. Zhao, 'The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses,' Mol Cancer, vol. 14, p. 87, Apr 17 2015. [51] S. Ribback, A. Cigliano, N. Kroeger, M. G. Pilo, L. Terracciano, M. Burchardt, et al., 'PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men,' Oncotarget, Apr 16 2015. [52] M. Lionello, S. Blandamura, L. Loreggian, G. Ottaviano, L. Giacomelli, R. Marchese-Ragona, et al., 'High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study,' J Oral Pathol Med, vol. 41, pp. 136-40, Feb 2012. [53] H. Ushijima, Y. Suzuki, T. Oike, M. Komachi, Y. Yoshimoto, K. Ando, et al., 'Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions,' J Radiat Res, Apr 16 2015. [54] A. Miyasaka, K. Oda, Y. Ikeda, K. Sone, T. Fukuda, K. Inaba, et al., 'PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-alpha/VEGF pathway in endometrial cancer,' Gynecol Oncol, Apr 22 2015. [55] W. L. Liu, M. Gao, K. Y. Tzen, C. L. Tsai, F. M. Hsu, A. L. Cheng, et al., 'Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma,' Oncotarget, vol. 5, pp. 3662-72, Jun 15 2014. [56] A. S. Yamashita, G. S. Baia, J. S. Ho, E. Velarde, J. Wong, G. L. Gallia, et al., 'Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors,' J Neurooncol, vol. 118, pp. 83-92, May 2014. [57] R. M. Castilho, C. H. Squarize, L. A. Chodosh, B. O. Williams, and J. S. Gutkind, 'mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging,' Cell Stem Cell, vol. 5, pp. 279-89, Sep 4 2009. [58] R. Iglesias-Bartolome, V. Patel, A. Cotrim, K. Leelahavanichkul, A. A. Molinolo, J. B. Mitchell, et al., 'mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis,' Cell Stem Cell, vol. 11, pp. 401-14, Sep 7 2012. [59] X. H. Li, D. Fu, N. H. Latif, C. P. Mullaney, P. H. Ney, S. R. Mog, et al., 'Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signaling,' Haematologica, vol. 95, pp. 1996-2004, Dec 2010. [60] C. Chen, Y. Liu, Y. Liu, and P. Zheng, 'mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells,' Sci Signal, vol. 2, p. ra75, 2009. [61] D. O. Stram and S. Mizuno, 'Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation,' Radiat Res, vol. 117, pp. 93-113, Jan 1989. [62] L. Geng and C. S. Potten, 'Changes after irradiation in the number of mitotic cells and apoptotic fragments in growing mouse hair follicles and in the width of their hairs,' Radiat Res, vol. 123, pp. 75-81, Jul 1990. [63] H. Aoki, A. Hara, T. Motohashi, and T. Kunisada, 'Keratinocyte stem cells but not melanocyte stem cells are the primary target for radiation-induced hair graying,' J Invest Dermatol, vol. 133, pp. 2143-51, Sep 2013. [64] A. V. Budanov and M. Karin, 'p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling,' Cell, vol. 134, pp. 451-60, Aug 8 2008. [65] K. Kobielak, H. A. Pasolli, L. Alonso, L. Polak, and E. Fuchs, 'Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA,' J Cell Biol, vol. 163, pp. 609-23, Nov 10 2003. [66] R. Kopan and E. Fuchs, 'A new look into an old problem: keratins as tools to investigate determination, morphogenesis, and differentiation in skin,' Genes Dev, vol. 3, pp. 1-15, Jan 1989. [67] L. Alonso and E. Fuchs, 'Stem cells of the skin epithelium,' Proc Natl Acad Sci U S A, vol. 100 Suppl 1, pp. 11830-5, Sep 30 2003. [68] E. Legue and J. F. Nicolas, 'Hair follicle renewal: organization of stem cells in the matrix and the role of stereotyped lineages and behaviors,' Development, vol. 132, pp. 4143-54, Sep 2005. [69] S. Muller-Rover, Y. Tokura, P. Welker, F. Furukawa, H. Wakita, M. Takigawa, et al., 'E- and P-cadherin expression during murine hair follicle morphogenesis and cycling,' Exp Dermatol, vol. 8, pp. 237-46, Aug 1999. [70] S. Elmore, 'Apoptosis: a review of programmed cell death,' Toxicol Pathol, vol. 35, pp. 495-516, Jun 2007. [71] A. A. Mills, 'Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins,' Nat Rev Cancer, vol. 10, pp. 669-82, Oct 2010. [72] S. Song and P. F. Lambert, 'Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction,' Am J Pathol, vol. 155, pp. 1121-7, Oct 1999. [73] C. J. Kemp, T. Wheldon, and A. Balmain, 'p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis,' Nat Genet, vol. 8, pp. 66-9, Sep 1994. [74] E. A. Klein and R. K. Assoian, 'Transcriptional regulation of the cyclin D1 gene at a glance,' J Cell Sci, vol. 121, pp. 3853-7, Dec 1 2008. [75] L. J. Kuo and L. X. Yang, 'Gamma-H2AX - a novel biomarker for DNA double-strand breaks,' In Vivo, vol. 22, pp. 305-9, May-Jun 2008. [76] A. Anandharaj, S. Cinghu, and W. Y. Park, 'Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy,' Acta Biochim Biophys Sin (Shanghai), vol. 43, pp. 292-300, Apr 2011. [77] J. Huelsken, R. Vogel, B. Erdmann, G. Cotsarelis, and W. Birchmeier, 'beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin,' Cell, vol. 105, pp. 533-45, May 18 2001. [78] P. S. Myung, M. Takeo, M. Ito, and R. P. Atit, 'Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration,' J Invest Dermatol, vol. 133, pp. 31-41, Jan 2013. [79] K. Inoki, H. Ouyang, T. Zhu, C. Lindvall, Y. Wang, X. Zhang, et al., 'TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth,' Cell, vol. 126, pp. 955-68, Sep 8 2006. [80] R. Baron and M. Kneissel, 'WNT signaling in bone homeostasis and disease: from human mutations to treatments,' Nat Med, vol. 19, pp. 179-92, Feb 2013. [81] H. Shimizu and B. A. Morgan, 'Wnt signaling through the beta-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells,' J Invest Dermatol, vol. 122, pp. 239-45, Feb 2004. [82] M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, et al., 'The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway,' Proc Natl Acad Sci U S A, vol. 96, pp. 5522-7, May 11 1999. [83] R. Lall, S. Ganapathy, M. Yang, S. Xiao, T. Xu, H. Su, et al., 'Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response,' Cell Death Differ, vol. 21, pp. 836-44, May 2014. [84] G. Xie, H. Wang, Z. Yan, L. Cai, G. Zhou, W. He, et al., 'Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage,' J Invest Dermatol, vol. 135, pp. 690-700, Mar 2015. [85] L. A. Mainwaring and A. M. Kenney, 'Divergent functions for eIF4E and S6 kinase by sonic hedgehog mitogenic signaling in the developing cerebellum,' Oncogene, vol. 30, pp. 1784-97, Apr 14 2011. [86] Y. Wang, Q. Ding, C. J. Yen, W. Xia, J. G. Izzo, J. Y. Lang, et al., 'The crosstalk of mTOR/S6K1 and Hedgehog pathways,' Cancer Cell, vol. 21, pp. 374-87, Mar 20 2012. [87] C. A. Callahan and A. E. Oro, 'Monstrous attempts at adnexogenesis: regulating hair follicle progenitors through Sonic hedgehog signaling,' Curr Opin Genet Dev, vol. 11, pp. 541-6, Oct 2001. [88] S. H. Paik, J. S. Yoon, H. H. Ryu, J. Y. Lee, C. Y. Shin, K. H. Min, et al., 'Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia,' Exp Dermatol, vol. 22, pp. 496-9, Jul 2013. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52518 | - |
dc.description.abstract | 放射治療是近年來常用的癌症療法之一,其特色在於可藉由具穿透性的游離輻射來對體內的病灶進行非侵入性的治療處置。然而,游離輻射會同時對病灶附近的正常組織造成傷害,因而產生對應的副作用症狀,其中,最明顯的副作用為落髮,會造成病人的觀感不佳、生活品質下降。如何減緩放療後的落髮症狀,是重要的研究課題之一。mTOR訊息傳遞路徑是細胞重要的接收營養、壓力訊號的分子訊息中樞之一,已知在皮膚及毛髮的修復過程中扮演重要的角色。然而,遭受游離輻射傷害時,在mTOR被抑制的情況下,有些組織反而增強對抗輻射的能力。我們想知道,對於毛髮受輻射傷害後,在mTOR被抑制時的傷害表現又是如何?
本研究使用32天大的雌性C57BL/6黑毛小鼠作為動物實驗對象,在施打mTOR抑制劑雷帕黴素(rapamycin)後施以全身游離輻射照射,而後持續施打雷帕黴素觀察至毛髮衰退期(telogen)。實驗結果發現,在4Gy以上的劑量下,施打雷帕黴素的小鼠在第5天開始有明顯的掉毛,而控制組則無。從背皮組織切片的H&E染色可以發現施打雷帕黴素的小鼠的毛囊,在第3天有較嚴重的變形,之後的修復狀況也較控制組差。免疫螢光染色的結果發現,施打雷帕黴素的小鼠其毛囊球部的基質細胞進行分裂的細胞較少,但自我凋亡的細胞數量則無差異;毛囊微結構染色發現施打雷帕黴素的小鼠毛囊,在第4天修復後的髮幹內心IRS及毛皮質部的結構並不正常。從細胞週期相關的調控蛋白的染色結果,本研究發現mTOR訊息路徑受抑制時,毛囊細胞受游離輻射影響而產生細胞週期停滯的現象,其持續時間會延長,間接影響到基質細胞進行增生、參與毛囊修復的能力。mTOR訊息路徑的抑制,也導致毛囊細胞在輻射傷害早期出現較多的DNA傷害。最後,本研究探討了與毛囊生長期生長調控相關的Wnt訊息路徑,並發現受輻射傷害的毛囊的修復後期,可能是由Wnt訊息路徑主導,而mTOR訊息路徑的抑制可能導致Wnt訊息路徑的活性受到影響,而造成修復後期的毛囊修復不佳的結果。 本研究證實了mTOR訊息路徑於受輻射傷害毛囊的修復機制中的重要性。 | zh_TW |
dc.description.abstract | Radiotherapy is one of the commonly used in cancer treatment. By use of ionizing radiation (IR), radiotherapy can kill cancer cells inside our bodies. However, IR can also cause damage to adjacent healthy tissues, resulting in various acute or chronic side effects. One of the most annoying side effects to is IR-induced alopecia, which is often seen after radiotherapy for head and neck neoplasm. There is currently no efficient treatment for IR-induced alopecia. mTOR signaling is a well-known signaling pathway responding to growth factors, nutrients, oxygen and energy level. mTOR signaling has been reported to be involved in regeneration processes in skin and hair. Whether mTOR can be a possible molecular target to prevent IR-induced alopecia is unknown. Here we explored this possibility.
Thirty two-day-old C57BL/6 mice were given mTOR inhibitor rapamycin and then exposed to IR. At 4 Gy of IR, inhibition of mTOR signaling resulted in more severe alopecia in 5 days. Histological analysis showed more severe hair follicle shortening and dystrophy. The self-repair for hair dystrophy was impaired. Further analysis showed that inhibition of mTOR signaling did not increased apoptosis but reduced cell proliferation with increased cell cycle arrest. In addition, differentiation of hair follicle was also compromised. Increased DNA damage intense at early time points after IR exposure was also observed. For molecular signaling, we found mTOR inhibition might inhibit the repair process by affecting Wnt signaling activity. This research demonstrated the possible role of mTOR signaling in hair follicle repair in response to IR. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T16:17:13Z (GMT). No. of bitstreams: 1 ntu-104-R02548002-1.pdf: 3438222 bytes, checksum: 3b7dcb7994d80d18feb430bcc6aa023a (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 口試委員會審定書 #
中文摘要 i ABSTRACT ii 致謝 iv 目錄 v 圖目錄 vii 表目錄 ix 第1章 緒論 1 1.1 放射治療及其副作用 1 1.2 概述毛囊結構與生理週期 2 1.2.1 毛囊的結構 2 1.2.2 毛髮的生長循環週期 3 1.3 游離輻射對生物體的傷害機制 6 1.3.1 輻射傷害於細胞層級 6 1.3.2 輻射傷害於組織層級 8 1.3.3 從輻射傷害中再生的策略 10 1.4 探索可能的關鍵路徑──mTOR訊息傳遞路徑 11 1.4.1 皮膚傷口修復與毛囊修復的關係 11 1.4.2 皮膚傷口修復中參與的分子訊息傳遞路徑 11 1.4.3 概述mTOR分子訊息傳遞路徑與雷帕黴素 13 1.5 mTOR訊息傳遞路徑於受游離輻射傷害的組織修復 16 第2章 實驗材料與方法 18 2.1 實驗設計 18 2.2 動物實驗 18 2.2.1 C57BL/6小鼠的實驗前處理 18 2.2.2 C57BL/6小鼠的游離輻射照射實驗 19 2.2.3 C57BL/6小鼠的背皮組織收集與處理 19 2.3 蘇木精─伊紅(hematoxylin & eosin, H&E)染色 20 2.4 免疫螢光(immunofluorescence, IF)染色 20 2.5 TUNEL檢測 22 2.6 定量與分析方法 23 2.6.1 毛囊長度的定量 23 2.6.2 增生細胞的定量 23 2.6.3 自我凋亡細胞的定量 24 第3章 實驗結果 25 3.1 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的背皮外觀變化的影響 25 3.2 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的毛囊組織結構變化的影響 28 3.3 驗證小鼠毛囊細胞的mTOR訊息路徑活性是否被抑制 34 3.4 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的毛囊微結構變化與細胞分化狀態的影響 37 3.5 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的毛囊細胞生存動態的影響 40 3.5.1 對細胞增生能力的影響 41 3.5.2 對細胞自我凋亡的影響 44 3.5.3 對細胞週期停滯的影響 46 3.6 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的毛囊細胞的DNA傷害程度的影響 50 3.7 mTOR訊息路徑的抑制對受游離輻射照射之C57BL/6小鼠的毛囊細胞的Wnt訊息路徑活性的影響 51 第4章 討論 55 第5章 結論 59 第6章 參考文獻 60 | |
dc.language.iso | zh-TW | |
dc.title | mTOR分子傳遞路徑在受游離輻射傷害的小鼠毛囊之修復機轉中的角色 | zh_TW |
dc.title | The role of mTOR signaling in hair follicle repair in response to ionizing radiation damage in mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 曹伯年(Po-Nien Tsao),楊宗霖(Tsung-Lin Yang) | |
dc.subject.keyword | 放射治療,落髮,mTOR訊息路徑,雷帕黴素,DNA傷害反應, | zh_TW |
dc.subject.keyword | radiotherapy,alopecia,mTOR signaling,rapamycin,DNA damage response, | en |
dc.relation.page | 70 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-17 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 3.36 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。